IPO Listed — 12 Jun 2026
Listing Price: ₹48.25
Hexagon Nutrition IPO GMP History | Listing Price ₹48.25 & Kostak Rate
Hexagon Nutrition IPO has been listed on June 12, 2026 at a listing price of ₹48.25, against the issue price of ₹45 — a gain of ₹3.25 (+7.22%). The GMP peaked at ₹12 on 5 June 2026 and reached a low of ₹0 on 3 June 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Hexagon Nutrition IPO raised ₹138.87 Cr. through its IPO at a price band of ₹42 to ₹45 per share, with a lot size of 333 shares. The IPO was open for subscription from 05 Jun 2026 to 09 Jun 2026.
GMP Trend Chart
Day-wise GMP Trend
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 12 Jun 2026 | ₹ 2.75 | 6.1% | ₹ 0 | ₹ 0 | |
| 09 Jun 2026 | ₹ 3.5 | 8% | ₹ 0 | ₹ 0 | |
| 08 Jun 2026 | ₹ 6.5 | 14% | ₹ 0 | ₹ 0 | |
| 06 Jun 2026 | ₹ 11.75 | 26% | ₹ 0 | ₹ 0 | |
| 05 Jun 2026 | ₹ 12 | 27% | ₹ 0 | ₹ 0 | |
| 04 Jun 2026 | ₹ 11.5 | 26% | ₹ 0 | ₹ 0 | |
| 03 Jun 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 02 Jun 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 29 May 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 27 May 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 26 May 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 |
Hexagon Nutrition IPO Dates
| Event | Date |
|---|---|
| Open Date | 05 Jun, 2026 |
| Close Date | 09 Jun, 2026 |
| Allotment Date | 10 Jun, 2026 |
| Refund Date | 11 Jun, 2026 |
| Credit to Demat | 11 Jun, 2026 |
| Listing Date | 12 Jun, 2026 |
Hexagon Nutrition IPO Actual Listing Price
| Basis | Value |
|---|---|
| Issue Price | ₹45 |
| GMP-Based Estimate (Pre-Listing) | ₹47 (+4.4%) |
| Actual Listing Price | ₹48.25 (+7.22%) |
| Listing Gain / Loss | +₹3.25 per share |
| Listing Date | 12 Jun, 2026 |
Is Hexagon Nutrition IPO GMP Reliable?
Grey market premium for Hexagon Nutrition IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- Cross-check before acting: Review the Hexagon Nutrition IPO full review for a fundamentals-based assessment before making any grey market trades.
Hexagon Nutrition IPO IPO Kostak Rate Explained
The Kostak rate for Hexagon Nutrition IPO was not active during the subscription period, as no grey market premium was established. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not active for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Hexagon Nutrition IPO
The company offers a wide range of products including micronutrient premixes, vitamin and mineral blends, protein supplements, ready-to-use therapeutic foods, and clinical nutrition products. Hexagon Nutrition follows a diversified business model catering to both B2B and B2C segments, supplying nutritional ingredients to food and pharmaceutical companies while also selling branded healthcare products. Its strong research and development capabilities, export network across multiple countries, and focus on affordable nutrition solutions have helped the company expand its market presence globally.
Strengths & Risks
Strengths
- ✓ Strong presence in clinical nutrition and micronutrient premix segment.
- ✓ Exports products to over 70 countries across global markets.
- ✓ Diversified product portfolio reduces dependence on single category revenue.
- ✓ Experienced promoter family with long operational industry expertise.
- ✓ Focus on research-driven and affordable nutrition healthcare solutions.
Risks
- ⚠ Raw material price fluctuations may impact operating profit margins.
- ⚠ High competition from established domestic and multinational nutrition companies.
- ⚠ Business depends heavily on regulatory approvals and compliance standards.
- ⚠ Export revenue exposure creates foreign currency fluctuation risks.
- ⚠ Dependence on healthcare and nutrition demand trends for growth.
Frequently Asked Questions about Hexagon Nutrition IPO
What is the GMP of Hexagon Nutrition IPO?
The current Grey Market Premium (GMP) of Hexagon Nutrition IPO is ₹ 2.75.
What is the Kostak Price of Hexagon Nutrition IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Hexagon Nutrition IPO is currently not available.
What is the Subject to Sauda Price of Hexagon Nutrition IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is currently not available.
What was the actual listing price of Hexagon Nutrition IPO?
Hexagon Nutrition IPO listed on June 12, 2026 at ₹48.25, against the issue price of ₹45 — a gain of +7.22%.
How did the GMP of Hexagon Nutrition IPO trend before listing?
The GMP of Hexagon Nutrition IPO was falling in its final days before listing. The GMP peaked at ₹12 on 5 June 2026. View the day-wise table above for the complete GMP history.
Explore Hexagon Nutrition IPO Further
For a complete picture before making your investment decision, explore these resources:
Discussion 0
No comments yet
Be the first to share your thoughts!